Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Cardiovasc. Med.

Sec. Cardiac Rhythmology

Analysis of Risk Factors for Early Recurrence After Radiofrequency Ablation in Patients with Atrial Fibrillation and Construction of a Nomogram Predictive Model

Provisionally accepted
Jia-Nan  WangJia-Nan Wang1Hui-Lan  LiuHui-Lan Liu1Hui-Hong  HongHui-Hong Hong1Ting-Pei  ZhuangTing-Pei Zhuang1Bing  WuBing Wu2*
  • 1Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, China
  • 2Quanzhou First hospital, Quanzhou, China

The final, formatted version of the article will be published soon.

Background: Early recurrence of atrial fibrillation (AF) after radiofrequency catheter ablation remains common and undermines procedural success. This study aimed to identify clinical, echocardiographic, and biochemical predictors of early atrial tachyarrhythmia recurrence and to construct a nomogram for individualized risk assessment. Methods: This retrospective cohort study included 276 consecutive patients with AF undergoing first-time radiofrequency catheter ablation between January 2021 and December 2024. Early recurrence was defined as any documented AF, atrial flutter, or atrial tachycardia lasting ≥30 s within 3 months post-procedure. All patients received short-term oral amiodarone for 3 months to cover the 90-day blanking period. Multivariable logistic regression was used to identify independent predictors. A nomogram was developed using the rms package in R. Discrimination was assessed using the area under the receiver operating characteristic curve (AUC). Internal validation and calibration were assessed using bootstrap resampling (1,000 iterations) with an optimism-corrected concordance index (C-index) and calibration plots, and clinical utility was evaluated using decision curve analysis (DCA). Results: Univariate analysis showed higher body mass index (BMI), larger left atrial diameter (LAD), higher B-type natriuretic peptide (BNP) levels, and higher prevalences of dyslipidemia, obstructive sleep apnea syndrome (OSAS), and persistent AF in patients with early recurrence (all p<0.05). Multivariable analysis identified BMI (per 1 kg/m²; OR 1.753, 95% CI 1.443–2.113; p<0.001), LAD (per 5 mm; OR 1.556, 95% CI 1.152–2.102; p=0.004), BNP (per 100 ng/L; OR 1.703, 95% CI 1.373– 2.053; p<0.001), persistent AF (OR 4.203, 95% CI 1.324–13.507; p=0.017), and OSAS (OR 3.405, 95% CI 1.081–11.005; p=0.041) as independent predictors. The nomogram showed acceptable discrimination (AUC 0.761, 95% CI 0.693–0.851), stable internal validation (optimism-corrected C-index 0.758), good calibration, and favorable net clinical benefit on DCA. Conclusions: Elevated BMI, enlarged LAD, increased BNP, persistent AF, and OSAS independently predict early atrial tachyarrhythmia recurrence after ablation. This nomogram may support individualized early post-ablation risk stratification, pending external validation in multicenter cohorts.

Keywords: Atrial Fibrillation, early recurrence, nomogram, obstructive sleep apnea syndrome, Radiofrequency catheter ablation

Received: 04 Jul 2025; Accepted: 27 Jan 2026.

Copyright: © 2026 Wang, Liu, Hong, Zhuang and Wu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Bing Wu

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.